AVITA Medical Inc

AVITA Medical, Inc. is a commercial-stage company focused on regenerative tissue, serving markets in the United States, Australia, and the United Kingdom. Its primary mission is to provide innovative regenerative solutions for significant unmet medical needs, particularly in the areas of burn and trauma injuries, chronic wounds, and various dermatological and aesthetic conditions such as vitiligo. At the core of its offerings is a patented and proprietary platform technology that harnesses the inherent regenerative capabilities found within a patient's own skin to develop therapeutic treatments. The company's flagship product, the RECELL System, is a medical device. It empowers healthcare professionals to generate a suspension of "Spray-On Skin" cells by utilizing a minimal sample of the patient's own skin. This innovative approach is specifically indicated for treating acute thermal burns in adults aged eighteen and above. Looking ahead, AVITA Medical is actively involved in strategic research collaborations. One such partnership with the University of Colorado School of Medicine aims to establish preclinical proof-of-concept for a spray-on therapy utilizing genetically corrected cells. Additionally, a collaboration with the Houston Methodist Research Institute focuses on investigating the molecular reversal of cellular aging via a novel cell suspension delivery method. The company underwent a name change in December 2020, transitioning from AVITA Therapeutics, Inc. to its current name, AVITA Medical, Inc. Founded in 2000, AVITA Medical, Inc. maintains its headquarters in Valencia, California.